Analyst firms · Barclays · TMO
Barclays TMO price target and rating history
Thermo Fisher Scientific Inc (TMO) · Industrials
Barclays rates Thermo Fisher Scientific Inc (TMO) Overweight with a $550 price target, as of its latest action on Sep 11, 2025. It has published 4 rating actions on TMO since January 2022, including 1 upgrade and 1 downgrade. Across 12 firms with a TMO price target in the last 12 months, the median target is $635.
- Current rating
- Overweight
- Price target
- $550
- Median target, all firms
- $635
- Actions on TMO
- 4
Barclays price target on TMO
Every Barclays rating on TMO
- Sep 11, 2025
- Jan 24, 2024
- Apr 4, 2023
- Jan 26, 2022
How other firms rate TMO
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Buy | $730 | Sep 9, 2026 |
| CLSA | Outperform | $748 | Sep 3, 2026 |
| Bernstein | Mkt Perform | $520 | Jun 26, 2026 |
| Piper Sandler | Neutral | $510 | Jun 11, 2026 |
| HSBC | Hold | $540 | Jun 3, 2026 |
| Wolfe Research | Outperform | $535 | Jun 2, 2026 |
| RBC Capital Markets | Sector Perform | $490 | May 15, 2026 |
| DZ Bank | Buy | $610 | Mar 27, 2026 |
| Citigroup | Buy | $660 | Dec 11, 2025 |
| Goldman Sachs | Buy | $685 | Dec 9, 2025 |
| KeyBanc Capital Markets | Overweight | $750 | Dec 8, 2025 |
| Morgan Stanley | Overweight | $670 | Dec 2, 2025 |
Questions about Barclays and TMO
- What is Barclays's price target for TMO?
- Barclays's latest stated price target for Thermo Fisher Scientific Inc (TMO) is $550, from its action on Sep 11, 2025.
- What is Barclays's rating on TMO?
- Barclays rates TMO Overweight, a bullish rating, as of Sep 11, 2025.
- When did Barclays last change its view on TMO?
- On Sep 11, 2025, Barclays upgrades to Overweight from Equal Weight, price target $550.
- How does Barclays's TMO target compare with other analysts?
- Across 12 firms with a TMO price target in the last 12 months, the median target is $635.
More TMO rating histories
All Barclays ratingsTMO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.